Temocapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C23H28N2O5S2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8G820I95VP, chemically known as 1,4-thiazepine-4-(5h)-acetic acid, 6-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2s-(2alpha,6beta(r*)))- but more generally known as temocapril hydrochloride, which bears US NIH Compound Identifier 71322. European Medicines Agency schedules Temocapril hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04716MIG. Most nations, for tariff and trade purposes, schedule temocapril hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, TEMOCAPRIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Temocapril hydrochloride bears US NLM identifiers UMLS ID C0208801 and NCI Concept Code C99556. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]2CS[C@@H](CN(C2=O)CC(=O)O)C3CCCS3.CL.